One hundred samples from healthy animals were screened for the presence of enterohaemorrhagic Escherichia coli 0157: H7 and 17 were positive for EHEC 0157:H7 after confirmation using serology kits. Antibiotic susceptibility patterns showed the isolates to be highly susceptible to the various antibiotics screened with a few showing multiple antibiotic resistance. The plasmid profiles revealed that 8/17 (47%) of the animal isolates harboured detectable plasmids ranging in size from 0.564 kb to >23 kb.

No abstract

Ten Nigerian medicinal plants used traditionally for the treatment of several ailments of both microbial and non-microbial origins were tested on multi-drug resistant S. typhi (MDR) strains of which six of them were active. The results revealed that both the aqueous and ethanol extracts of Terminalia avicennioides, Momordica balsamina, Combretum paniculatum and Trema guineensis were effective on the MDR-S. typhi strains with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values ranging from 9.60 to 14 mcg/ml and 24 to 33 mcg/ml, respectively. Whereas, only the aqueous extracts of Morinda lucida and Ocimum gratissimum were found to be active against this pathogen with MIC and MBC values of 9.60 and 24 mcg/ml for M. lucida, 40 and 55 mcg/ml for O. gratissimum, respectively. There was no statistical significant difference (P > 0.05) between the activity of each plant extract and the decoctions prepared from them. All the six active plants showed positive reactions to alkaloids, tannins, flavonoids and anthraquinones but in variable degrees. All but M. balsamina, indicated the presence of saponin.

Ten Nigerian medicinal plants used traditionally for the treatment of several ailments of both microbial and non-microbial origins were tested on multi-drug resistant S. typhi (MDR) strains of which six of them were active. The results revealed that both the aqueous and ethanol extracts of Terminalia avicennioides, Momordica balsamina, Combretum paniculatum and Trema guineensis were effective on the MDR-S. typhi strains with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values ranging from 9.60 to 14 mcg/ml and 24 to 33 mcg/ml, respectively. Whereas, only the aqueous extracts of Morinda lucida and Ocimum gratissimum were found to be active against this pathogen with MIC and MBC values of 9.60 and 24 mcg/ml for M. lucida, 40 and 55 mcg/ml for O. gratissimum, respectively. There was no statistical significant difference (P > 0.05) between the activity of each plant extract and the decoctions prepared from them. All the six active plants showed positive reactions to alkaloids, tannins, flavonoids and anthraquinones but in variable degrees. All but M. balsamina, indicated the presence of saponin.

Because of the emergence of drug-resistant Klebsiella strains in many hospitals, the distribution of the serotypes was reexamined to determine whether there was any correlation between the serotype and the site of isolation from the body, the antimicrobial susceptibility pattern, or the place of acquisition of the organism (hospital or community). One hundred consecutive isolates of Klebsiella pneumoniae from different patients were typed as 1, 2, 3, 4, 5, 6, or greater than 6. Of these, 8 of 28 strains isolated from respiratory secretions were serotype 2 (9 typable strains), 6 of 24 wound isolates were serotype 3 (8 typable strains), and the urine isolates varied in their serotypes. Regardless of serotype, most strains appeared mucoid on blood and MacConkey agars. Twenty-six percent of the isolates were resistant to at least one antimicrobial agent. No correlation was found between the serotypes and the antibiotic resistance; however, strains isolated within 25 days of admission to the hospital from the community were all susceptible. It appears that although there may be a correlation between the serotype and isolation from some sites of the body, knowledge of the serotype of the organism cannot predict the antimicrobial susceptibility pattern. The clinician's choice of antibiotic therapy should depend largely on whether the Klebsiella strain was acquired by the patient in the community (0% resistant) or in the hospital (31% resistant).